Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karla V Ballman

Showing results (1-10 of 229) with videos related to

Pageof 23
Sort By:
American Journal of Respiratory and Critical Care Medicine|December 2, 2016
Surprising Results from an Angiotensin-Converting Enzyme Inhibitor Trial in Patients with Chronic Obstructive Pulmonary DiseaseKarla V Ballman
Circulation|October 8, 2008
Genetics and genomics: gene expression microarraysKarla V Ballman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2014
Reply to D.M. Hyman et al and M. Voskoboynik et alKarla V Ballman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2026
Lessons From GBM AGILE's Regorafenib Experience in Newly Diagnosed and Recurrent GlioblastomaKarla V Ballman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2014
Phase I trial improvement: a question of patient selection, trial design, or both?Karla V Ballman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2016
Reply to M. MindenKarla V Ballman
Chinese Clinical Oncology|September 27, 2015
Biomarker-based trials in neuro-oncologyKarla V Ballman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2015
Biomarker: Predictive or Prognostic?Karla V Ballman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2026
Less Isn't Simple: Insights From Postmastectomy Radiotherapy Deintensification TrialsRobert W Mutter, Karla V Ballman
Cancer Informatics|March 5, 2009
What does PLIER really do?Terry M Therneau, Karla V Ballman
Pageof 23

Showing results (1-10 of 229) with videos related to

Sort By:
Pageof 23
American Journal of Respiratory and Critical Care Medicine|December 2, 2016
Surprising Results from an Angiotensin-Converting Enzyme Inhibitor Trial in Patients with Chronic Obstructive Pulmonary DiseaseKarla V Ballman
Circulation|October 8, 2008
Genetics and genomics: gene expression microarraysKarla V Ballman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2014
Reply to D.M. Hyman et al and M. Voskoboynik et alKarla V Ballman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2026
Lessons From GBM AGILE's Regorafenib Experience in Newly Diagnosed and Recurrent GlioblastomaKarla V Ballman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2014
Phase I trial improvement: a question of patient selection, trial design, or both?Karla V Ballman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2016
Reply to M. MindenKarla V Ballman
Chinese Clinical Oncology|September 27, 2015
Biomarker-based trials in neuro-oncologyKarla V Ballman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2015
Biomarker: Predictive or Prognostic?Karla V Ballman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 31, 2026
Less Isn't Simple: Insights From Postmastectomy Radiotherapy Deintensification TrialsRobert W Mutter, Karla V Ballman
Cancer Informatics|March 5, 2009
What does PLIER really do?Terry M Therneau, Karla V Ballman
Pageof 23